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INTRODUCTION
Immunoglobulin G (IgG) antibodies have structural 
conformations that can be studied using Förster 
Resonance Energy Transfer (FRET) at the single-
molecule level. An antibody is a very flexible protein 
composed of four chains (two heavy and two light) and 
has a Y-shaped structure as shown in Figure 1. The 
lower portion contains a constant region (Fc fragment) 
that is composed of similar amino acids found in all 
antibody molecules whereas the upper portion is the 
“variable region” (two Fab fragments) with varying 
amino acids that results in antibodies that specifically 
bind different antigen molecules. The stem region 
contains carbohydrates, or sugar molecules, that 
provide shape to the Fc region. Previous studies have 
shown that if the sugars are removed, the antibody is 
unable to elicit an immune response2. The purpose of 
this research is to examine the distribution of antibody 
structures with and without the sugars present in order 
to study whether different conformations are present, 
what happens to conformations once the carbohydrates 
are removed, and if there is a preferred conformation. 
The IgG antibody used in this research is the 39C2 
catalytic aldolase antibody.
FRET was the chosen technique to determine the 
distances between areas of interest such as between 
the two portions of the Fc region near the carbohydrate 
groups on the antibody and between the antigen-binding 
sites. FRET requires the use of two dye molecules, 
a donor and an acceptor. These dye molecules can 
covalently bond to macromolecules and are used for 
fluorescence spectroscopy, as they absorb and fluoresce 
visible light. Once the donor molecule is excited, it can 
transfer energy to the acceptor molecule which proceeds 
to fluoresce. The closer the acceptor is to the donor, the 
more likely it is that energy transfer will take place.  
Therefore, the relative amounts of donor and acceptor 
fluorescence can be used to calculate the distance 
between the donor and acceptor molecules, resulting 
A B S T R A C T Antibodies are Y-shaped, flexible proteins whose structures can be studied using Förster Resonance 
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out FRET studies of antibodies. In order to label the binding sites of an antibody, dye molecules were attached to a 
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(UV-Vis) spectroscopy.  To label the stem region of a humanized immunoglobulin G (IgG) antibody, the DNA for this 
antibody was mutated to introduce a cysteine residue to which dyes can be attached.  In this research, the DNA was 
sequenced and checked to provide the desired sequence for protein production.
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in the ability to determine structural information about 
the protein2 (Figure 2). Single molecule FRET can be 
used to obtain a histogram of the distances between 
the donor and acceptor sites on the antibody3,4. Single 
molecule spectroscopy was the method chosen as it 
examines one molecule at a time rather than multiple 
molecules at once.
In order to study the distance between the antigen-
binding sites of an antibody, dye molecules were 
attached to a hapten, or a small molecule that specifically 
adheres to the binding site of an antibody.  This dye-
hapten conjugate was then reacted with the antibody to 
observe the degree of binding.  FRET experiments were 
performed on this system, but no significant energy 
transfer was observed.  So as to attach dye molecules to 
the Fc region, manipulation of the DNA of a humanized 
(part mouse, part human) IgG antibody was necessary.  
The DNA sequences for the light and heavy chains of 
the humanized IgG antibody were checked for unwanted 
mutations.  A satisfactory sequence has been obtained 
and submitted to a company for the production of the 
antibody.  The labeling of the antigen binding sites and 
the examination of the humanized IgG DNA sequence 
are both described below.
METHODS
PROTEIN SEQUENCE ANALYSIS 
From previous research, the Stratagene QuikChange 
Lightning Site Directed Mutagenesis Kit was used to 
introduce a cysteine point mutation into the CH2 region 
of the Fc region. The cysteine point mutation allows for 
dye attachment, crucial for FRET spectroscopy analysis. 
The sequences were checked using the CLC Sequence 
Viewer (Figure 3). Literature references for the plasmids 
were provided so as to determine the desired amino 
acid sequences for the light and heavy chains of the IgG 
antibody by comparison5-7.
DYE ATTACHMENT
The carboxylic acid form of the hapten was previously 
reacted with reagents to generate the succinimidyl 
ester form of the hapten. The product was reacted with 
the donor and acceptor dye molecules (AlexaFluor® 
568 and Cy 5.5®). Thin layer chromatography (TLC) 
was used to establish a desired solvent system, found 
to be a 60:40 mixture of methanol and ethyl acetate. 
A ThermoScientific NanoDrop 1000 UV-Visible 
Spectrometer was used to study the concentration of 
the samples and to determine the percent of antibody 
binding sites labeled with the dye-hapten. The UV-
Visible Spectrometer displayed a peak at 318 nm which 
indicates an enaminone, the product of the hapten 
binding to the antibody, is present.
RESULTS
The protein sequences were analyzed and the desired 
DNA and amino acid sequences for the light (plasmid 
5.3) and heavy (plasmid 6.4) chains of the humanized 
IgG antibody were obtained and sent to Creative 
BioLabs for protein production. There were no unwanted 
mutations in the light chain. However, the heavy chain 
is the area in which the DNA mutation was executed and 
the new sequence includes the cysteine point mutation 
into the CH2 region of the Fc region. Figure 4 presents 
the desired sequence for the heavy chain. There were 
sequence errors found in the variable heavy chain that 
will be fixed by Creative BioLabs.
Once the protein sequences were analyzed, UV-Vis 
spectroscopy was used to determine if there is evidence 
for dye labeling. It was found that approximately 
85% of the binding sites of the antibody were labeled 
with a dye molecule. As evidenced by Figure 5, there 
is a substantial peak around 568 nm signifying the 
AlexaFluor® 568 donor dye fluorophore and a peak at 
about 680nm, characteristic of the Cy 5.5® acceptor 
dye fluorophore. There is also an evident peak at 
318nm, denoting the enaminone formed which is the 
product of the hapten binding to the antibody. FRET 
experiments were performed on this sample; however, 
substantial energy transfer was not observed and further 
experiments are necessary.
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CONCLUSION
The results demonstrate it was possible to optimize 
dye attachment to the 38C2 antibody and UV-Visible 
spectroscopy provides evidence that the antibody was 
labeled with the AlexaFluor® 568 donor dye fluorophore 
and the Cy 5.5® acceptor dye fluorophore. Furthermore, 
the light and heavy DNA sequences were checked for 
any unwanted mutations and the desired sequences 
were found and sent to create the protein sequence. 
Based on this and previous research, it will be possible 
to label the purified protein with the dye molecules and 
to perform single-molecule FRET spectroscopy. FRET 
will examine any possible antibody conformations.
 
The structure of an immunoglobulin G (IgG) molecule.
The regions of the antibody that correspond to the Fab (upper,
antigen-binding fragment), the Fc (lower, crystallizable, constant
fragment), and the hinge region are also shown. The location of the
sugars, which are bound to the Fc fragment, is indicated.
.
FIGURE 1
 
 
 
 
  
Antigen-binding 
Sites 
Hinge 
Region 
 
 
 
  
 
  
 
 
 
 
 
 
 
Fab 
Fragment 
Fc 
Fragment 
  
  
   Sugars 
 
Example of a section of the protein sequence. Evidence of a cysteine 
point mutation in which cysteine was changed to guanine.
FIGURE 3
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From previous research, the Stratagene QuikChange Lightning Site Directed Mutagenesis 
Kit was used to introduce a cysteine point mutation into the CH2 region of the Fc region. The 
cysteine point mutation allows for dye attachment, crucial for FRET spectroscopy analysis. The 
sequences were checked using the CLC Sequence Viewer (Figure 3). Literature references for 
the plasmids were provided so as to determine the desired amino acid sequences for the light and 
heavy chains of the IgG antibody by comparison5-7. 
 
Dye Attachment: 
The carboxylic acid form of the hapten was previously reacted with reagents to generate 
the succinimidyl ester form of the hapten. The product was reacted with the donor and acceptor 
dye molecules (AlexaFluor® 568 and Cy 5.5®). Thin layer chromatography (TLC) was used to 
establish a desired solvent system, found to be a 60:40 mixture of methanol and ethyl acetate. A 
ThermoScientific NanoDrop 1000 UV-Visible Spectrometer was used to study the concentration 
of the samples and to determine the percent of antibody binding sites labeled with the dye-
 
Figure 3. Example of a section of the protein 
sequence. Evidence of a cysteine point 
mutation in which cysteine was changed to 
guanine.  
 
 
Illustrations of FRET, in which a donor molecule (D) undergoes 
distance-dependent energy transfer to an acceptor molecule (A), 
causing A to fluoresce. The amount of fluorescence observed from 
D and A can be used to determine the distance between the two 
molecules. The antibodies shown are from the protein data bank, 
Harris, L. J.; Larson, S. B.; Hasel, K. W.; McPherson, A. Biochemistry, 
1997, 36, 1581.
.
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In order to study the distance between the antigen-binding sites of an antibody, dye 
molecules were attached to a hapte , or a small molecule that specifically adheres to the binding 
site of an antibody.  This dye-hapten conjugate was then reacted with the antibody to observe the 
degree of binding.  FRET experiments were performed on this system, but no significant energy 
transfer was observed.  So as to attach dye molecules to the Fc region, manipulation of the DNA 
of a humanized (part mouse, part human) IgG antibody was necessary.  The DNA sequences for 
the light and heavy chains of the humanized IgG antibody were checked for unwanted mutations.  
A satisfactory sequence has been obtained and submitted to a company for the production of the 
antibody.  The labeling of the antigen binding sites and the examination of the humanized IgG 
DNA sequence are both described below. 
 
Methods 
Protein Sequence Analysis:  
Figure 2. Illustrations of 
FRET, in which a donor 
molecule (D) undergoes 
distance-dependent energy 
transfer to an acceptor 
molecule (A), causing A to 
fluoresce. The amount of 
fluorescence observed from 
D and A can be used to 
determine the distance 
between the two molecules. 
The antibodies shown are 
from the protein data bank, 
Harris, L. J.; Larson, S. B.; 
Hasel, K. W.; McPherson, 
A. Biochemistry, 1997, 36, 
1581. 
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The desired DNA sequence of 6.4 plasmid for the CH2 region of the 
heavy chain which contains the cysteine point mutation.
FIGURE 4
6 
hapten. The UV-Visible Spectrometer displayed a peak at 318 nm which indicates an enaminone, 
the product of the hapten binding to the antibody, is present. 
 
Results 
The protein sequences were analyzed and the desired DNA and amino acid sequences for 
the light (plasmid 5.3) and heavy (plasmid 6.4) chains of the humanized IgG antibody were 
obtained and sent to Creative BioLabs for protein production. There were no unwanted mutations 
in the light chain. However, the heavy chain is the area in which the DNA mutation was 
executed and the new sequence includes the cysteine point mutation into the CH2 region of the 
Fc region. Figure 4 presents the desired sequence for the heavy chain. There were sequence 
errors found in the variable heavy chain that will be fixed by Creative BioLabs. 
  
 
Once the protein sequences were analyzed, UV-Vis spectroscopy was used to determine 
if there is evidence for dye labeling. It was found that approximately 85% of the binding sites of 
the antibody were labeled with a dye molecule. As evidenced by Figure 5, there is a substantial 
peak around 568 nm signifying the AlexaFluor® 568 donor dye fluorophore and a peak at about 
680nm, characteristic of the Cy 5.5® acceptor dye fluorophore. There is also an evident peak at 
318nm, denoting the enaminone formed which is the product of the hapten binding to the 
CH2 sequence: 
GCACCTGAACTCCTGGGGGGACCGTCA
GTCTTCCTCTTCCCCCCAAAACCCAAG
GACACCCTCATGATCTGCCGGACCCCT
GAGGTCACATGCGTGGTGGTGGACGTG
AGCCACGAAGACCCTGAGGTCAAGTTC
AACTGGTACGTGGACGGCGTGGAGGTG
CATAATGCCAAGACAAAGCCGCGGGAG
GAGCAGTACAACAGCACGTACCGTGTG
GTCAGCGTCCTCACCGTCCTGCACCAG
GACTGGCTGAATGGCAAGGAGTACAAG
TGCAAGGTCTCCAACAAAGCCCTCCCA
GCCCCCATCGAGAAAACCATCTCCAAA
GCCAAA 
Figure 4. The desired DNA sequence of 6.4 
plasmid for the CH2 region of the heavy 
chain which contains the cysteine point 
mutation. 
 
Illustration of the UV-Vis sprectroscopy of the dye-hapten to determine 
percent of binding sites occupied on the 38C2 antibody. Peaks for the 
enaminone, donor and acceptor dye fluorophoes are evident.
FIGURE 5
7 
antibody. FRET experiments were performed on this sample; however, substantial energy 
transfer was not observed and further experiments are necessary. 
 
 
Conclusion  
  The results demonstrate it was possible to opti ize dye attachment to the 38C2 antibody 
and UV-Visible spectrosc p  provides evid nc  that the antibody was labeled with the 
AlexaFluor® 568 donor dye fluorophore and the Cy 5.5® acceptor dye fluorophore. Furthermore, 
the light and heavy DNA sequences were checked for any unwanted mutations and the desired 
sequences were found and sent to create the protein sequence. Based on this and previous 
research, it will be possible to label the purified protein with the dye molecules and to perform 
single-molecule FRET spectroscopy. FRET will examine any possible antibody conformations. 
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